Medscape is available in 5 Language Editions – Choose your Edition here.


Meconium Aspiration Syndrome Treatment & Management

  • Author: Melinda B Clark, MD; Chief Editor: Ted Rosenkrantz, MD  more...
Updated: Jan 14, 2014

Medical Care

The American College of Obstetricians and Gynecologists continues to provide guidance regarding the appropriate indications for delivery to prevent neonatal complications of a prolonged pregnancy as well as avoiding the unnecessary delivery of a preterm baby.[10, 11]

In patients with meconium aspiration syndrome (MAS), thorough cardiac examination and echocardiography are necessary to evaluate for congenital heart disease and persistent pulmonary hypertension of the newborn (PPHN).

Confirming the degree of pulmonary hypertension, prior to instituting therapy, is extremely important.

Prevention of meconium aspiration syndrome (MAS)

Prevention is paramount. Obstetricians should closely monitor fetal status in an attempt to identify fetal distress.

When meconium is detected, amnioinfusion with warm, sterile saline is theoretically beneficial to dilute the meconium in the amniotic fluid, thereby minimizing the severity of the aspiration. However, current evidence does notsupport routine amnioinfusion to prevent meconium aspiration syndrome.[12, 13, 14] One large, multicenter study determined that amnioinfusion did not reduce the risk of moderate or severe meconium aspiration syndrome or meconium aspiration syndrome–related death.[15]

Current recommendations no longer advise routine intrapartum suctioning for infants born to mothers with meconium staining of the amniotic fluid.[16, 17]

When aspiration occurs, intubation and immediate suctioning of the airway can remove much of the aspirated meconium.

No clinical trials justify suctioning based on the consistency of meconium. Do NOT perform the following harmful techniques in an attempt to prevent aspiration of meconium-stained amniotic fluid:

  • Squeezing the chest of the baby
  • Inserting a finger into the mouth of the baby

The American Academy of Pediatrics Neonatal Resuscitation Program Steering Committee and the American Heart Association have promulgated guidelines for management of the baby exposed to meconium. The guidelines are under continuous review and are revised as new evidence-based research becomes available. The guidelines are as follows[18] :

  • If the baby is not vigorous (defined as depressed respiratory effort, poor muscle tone, and/or heart rate < 100 beats/min): Use direct laryngoscopy, intubate, and suction the trachea immediately after delivery. Suction for no longer than 5 seconds. If no meconium is retrieved, do not repeat intubation and suction. If meconium is retrieved and no bradycardia is present, reintubate and suction. If the heart rate is low, administer positive pressure ventilation and consider suctioning again later.
  • If the baby is vigorous (defined as normal respiratory effort, normal muscle tone, and heart rate >100 beats/min): Do not electively intubate. Clear secretions and meconium from the mouth and nose with a bulb syringe or a large-bore suction catheter.
  • In both cases, the remainder of the initial resuscitation steps should ensue, including drying, stimulating, repositioning, and administering oxygen as necessary.

Continued care in the neonatal ICU (NICU)

Maintain an optimal thermal environment to minimize oxygen consumption.

Minimal handling is essential because these infants are easily agitated. Agitation can increase pulmonary hypertension and right-to-left shunting, leading to additional hypoxia and acidosis. Sedation may be necessary to decrease agitation.

An umbilical artery catheter should be inserted to monitor blood pH and blood gases without agitating the infant.

Continue respiratory care. Oxygen therapy via hood or positive pressure is crucial in maintaining adequate arterial oxygenation. Mechanical ventilation is required by approximately 30% of infants with meconium aspiration syndrome.[5] Make concerted efforts to minimize the mean airway pressure and to use as short an inspiratory time as possible. Oxygen saturations should be maintained at 90-95%.

Surfactant therapy is commonly used to replace displaced or inactivated surfactant and as a detergent to remove meconium.[19, 20, 21] Although surfactant use does not appear to affect mortality rates, it may reduce the severity of disease, progression to extracorporeal membrane oxygenation (ECMO),[22] and decrease length of hospital stay.

Although conventional ventilation commonly is initially used, high-frequency oscillation and jet ventilation are alternative effective therapies. Hyperventilation to induce hypocapnia and compensate for metabolic acidosis is no longer a primary therapy for pulmonary hypertension because hypocarbia often results in decreased cerebral perfusion (PaCO2 < 30 mm Hg). Prolonged alkalosis has been shown to cause neuronal injury in animals and humans, providing another reason to avoid alkalosis in these patients.[23]

Ventilator therapy aimed at minimizing mean airway pressure and tidal vlume should be used if pulmonary interstitial emphysema or a pneumothorax is present.

For treatment of persistent pulmonary hypertension of the newborn (PPHN), inhaled nitric oxide is the pulmonary vasodilator of choice.[24] Oxygen is also a potent pulmonary vasculature vasodilator. Phosphodiesterase inhibitors, including sildenafil and milrinone, are being increasingly used as adjunctive therapies for PPHN.

Pay careful attention to systemic blood volume and blood pressure. Volume expansion, transfusion therapy, and systemic vasopressors are critical in maintaining systemic blood pressure greater than pulmonary blood pressure, thereby decreasing the right-to-left shunt through the patent ductus arteriosus. Dopamine is often the first-line vasopressor for neonates with meconium aspiration syndrome requiring vasopressor support.

Ensure adequate oxygen carrying capacity by maintaining the hemoglobin concentration of at least 13 g/dL.

Corticosteroids are not recommended. Evidence supporting the use of steroids in the management of meconium aspiration syndrome is insufficient.[25]

Neonates with meconium aspiration syndrome have historically been routinely treated with empiric broad-spectrum antibiotics, but this practice is being increasingly called into question. No studies have shown prophylactic antibiotics to reduce the incidence of sepsis in neonates born through meconium-stained amniotic fluid; thus, antibiotic use may be reserved for suspected or documented infections.

Extracorporeal membrane oxygenation (ECMO) is used if all other therapeutic options have been exhausted. Although effective in treating meconium aspiration syndrome, ECMO is associated with a high incidence of poor neurologic outcomes.


Evaluation by a pediatric cardiologist is necessary for echocardiographic assessment of the cardiac structures and to assess the severity of pulmonary hypertension and right-to-left shunting.

Evaluation by a pediatric neurologist is helpful in the presence of neonatal encephalopathy or seizure activity.


Although initial stabilization is necessary at community hospitals, infants with meconium aspiration syndrome frequently require high-frequency ventilation, inhaled nitric oxide (NO), or extracorporeal membrane oxygenation (ECMO). Therefore, infants with a significant aspiration should be transferred to a regional neonatal ICU (NICU) as soon as possible.


Perinatal distress and severe respiratory distress preclude feeding.

Intravenous fluid therapy begins with adequate dextrose infusion to prevent hypoglycemia. Intravenous fluids should be provided at mildly restricted rates (60-70 mL/kg/d).

Progressively add electrolytes, protein, lipids, and vitamins to ensure adequate nutrition and prevent essential amino acid and essential fatty acid deficiencies.

Outpatient care

Infants with meconium aspiration syndrome are at increased risk for adverse developmental outcomes and should be referred for developmental assessment as an outpatient


Surgical Care

Although primary management of air block syndromes (pneumothorax or pneumopericardium) is achieved by thoracic drainage tubes inserted by a neonatologist, a pediatric surgical consultation may be necessary in severe cases. Therapy with fibrin glue has been shown to be effective in patients with a persistent air leak.[26]

Contributor Information and Disclosures

Melinda B Clark, MD Associate Professor of Pediatrics, Department of Pediatrics, Albany Medical College

Melinda B Clark, MD is a member of the following medical societies: Alpha Omega Alpha, Academic Pediatric Association, American Academy of Pediatrics, Medical Society of the State of New York

Disclosure: Nothing to disclose.


David A Clark, MD Chairman, Professor, Department of Pediatrics, Albany Medical College

David A Clark, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American Pediatric Society, Christian Medical and Dental Associations, Medical Society of the State of New York, New York Academy of Sciences, Society for Pediatric Research

Disclosure: Nothing to disclose.

Specialty Editor Board

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Brian S Carter, MD, FAAP Professor of Pediatrics, University of Missouri-Kansas City School of Medicine; Attending Physician, Division of Neonatology, Children's Mercy Hospital and Clinics; Faculty, Children's Mercy Bioethics Center

Brian S Carter, MD, FAAP is a member of the following medical societies: Alpha Omega Alpha, American Academy of Hospice and Palliative Medicine, American Academy of Pediatrics, American Pediatric Society, American Society for Bioethics and Humanities, American Society of Law, Medicine & Ethics, Society for Pediatric Research, National Hospice and Palliative Care Organization

Disclosure: Nothing to disclose.

Chief Editor

Ted Rosenkrantz, MD Professor, Departments of Pediatrics and Obstetrics/Gynecology, Division of Neonatal-Perinatal Medicine, University of Connecticut School of Medicine

Ted Rosenkrantz, MD is a member of the following medical societies: American Academy of Pediatrics, American Pediatric Society, Eastern Society for Pediatric Research, American Medical Association, Connecticut State Medical Society, Society for Pediatric Research

Disclosure: Nothing to disclose.

  1. Singh BS, Clark RH, Powers RJ, Spitzer AR. Meconium aspiration syndrome remains a significant problem in the NICU: outcomes and treatment patterns in term neonates admitted for intensive care during a ten-year period. J Perinatol. 2009 Jul. 29(7):497-503. [Medline].

  2. Janssen DJ, Carnielli VP, Cogo P, et al. Surfactant phosphatidylcholine metabolism in neonates with meconium aspiration syndrome. J Pediatr. 2006 Nov. 149(5):634-9. [Medline].

  3. Clark DA, Nieman GF, Thompson JE, et al. Surfactant displacement by meconium free fatty acids: an alternative explanation for atelectasis in meconium aspiration syndrome. J Pediatr. 1987 May. 110(5):765-70. [Medline].

  4. Terasaka D, Clark DA, Singh BN, Rokahr J. Free fatty acids of human meconium. Biol Neonate. 1986. 50(1):16-20. [Medline].

  5. Wiswell TE, Tuggle JM, Turner BS. Meconium aspiration syndrome: have we made a difference?. Pediatrics. 1990 May. 85(5):715-21. [Medline].

  6. Yoder BA, Kirsch EA, Barth WH, Gordon MC. Changing obstetric practices associated with decreasing incidence of meconium aspiration syndrome. Obstet Gynecol. 2002 May. 99(5 Pt 1):731-9. [Medline].

  7. Singh BS, Clark RH, Powers RJ, Spitzer AR. Meconium aspiration syndrome remains a significant problem in the NICU: outcomes and treatment patterns in term neonates admitted for intensive care during a ten-year period. J Perinatol. 2009 Jul. 29(7):497-503. [Medline].

  8. Ghidini A, Spong CY. Severe meconium aspiration syndrome is not caused by aspiration of meconium. Am J Obstet Gynecol. 2001 Oct. 185(4):931-8. [Medline].

  9. Balchin I, Whittaker JC, Lamont RF, Steer PJ. Maternal and fetal characteristics associated with meconium-stained amniotic fluid. Obstet Gynecol. 2011 Apr. 117(4):828-35. [Medline].

  10. American College of Obstetricians and Gynecologists. ACOG Committee Opinion No 579: Definition of term pregnancy. Obstet Gynecol. 2013 Nov. 122(5):1139-40. [Medline].

  11. American College of Obstetricians and Gynecologists. ACOG committee opinion no. 561: Nonmedically indicated early-term deliveries. Obstet Gynecol. 2013 Apr. 121(4):911-5. [Medline].

  12. ACOG Committee No. 346: Amnioinfusion Does Not Prevent Meconium Aspiration Syndrome. Obstet & Gynecol. Oct 2006. 108(4):1053-1055.

  13. Velaphi S, Vidyasagar D. Intrapartum and postdelivery management of infants born to mothers with meconium-stained amniotic fluid: evidence-based recommendations. Clin Perinatol. 2006 Mar. 33(1):29-42. [Medline].

  14. Hofmeyr GJ, Xu H. Amnioinfusion for meconium-stained liquor in labour. Cochrane Database Syst Rev. 2010 Jan 20. CD000014. [Medline].

  15. Fraser WD, Hofmeyr J, Lede R, et al. Amnioinfusion for the prevention of the meconium aspiration syndrome. New Eng Journal of Medicine. 2005. 353:909-917.

  16. ACOG Committee Opinion No. 379: Management of delivery of a newborn with meconium-stained amniotic fluid. Obstet Gynecol. 2007 Sep. 110(3):739. [Medline].

  17. Vain NE, Szyld EG, Prudent LM, Wiswell TE, Aguilar AM, Vivas NI. Oropharyngeal and nasopharyngeal suctioning of meconium-stained neonates before delivery of their shoulders: multicentre, randomised controlled trial. Lancet. 2004 Aug 14-20. 364(9434):597-602. [Medline].

  18. [Guideline] Neonatal resuscitation: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Kattwinkel J, Perlman JM, Aziz K, Colby C, Fairchild K, GallagherJ, Hazinski MF, Halamek LP, Kumar P, Little G, McGowan JE, Nightengale B, Ramirez MM, Ringer S, Simon WM, Weiner GM, Wyckoff M, ZaichkinJ. Circulation. 2010. 122:S909 –S919.

  19. Wiswell TE, Knight GR, Finer NN, Donn SM, Desai H, Walsh WF. A multicenter, randomized, controlled trial comparing Surfaxin (Lucinactant) lavage with standard care for treatment of meconium aspiration syndrome. Pediatrics. 2002 Jun. 109(6):1081-7. [Medline].

  20. Dargaville PA, Mills JF. Surfactant therapy for meconium aspiration syndrome: current status. Drugs. 2005. 65(18):2569-91. [Medline].

  21. Dargaville PA. Innovation in surfactant therapy I: surfactant lavage and surfactant administration by fluid bolus using minimally invasive techniques. Neonatology. 2012. 101(4):326-36. [Medline].

  22. El Shahed AI, Dargaville P, Ohlsson A, Soll RF. Surfactant for meconium aspiration syndrome in full term/near term infants. Cochrane Database of Systematic Reviews. 2007. 2:[Full Text].

  23. Collins MP, Lorenz JM, Jetton JR, Paneth N. Hypocapnia and other ventilation-related risk factors for cerebral palsy in low birth weight infants. Pediatr Res. 2001 Dec. 50(6):712-9. [Medline].

  24. Abman SH, Kinsella JP. Inhaled nitric oxide therapy for pulmonary disease in pediatrics. Curr Opin Pediatr. 1998 Jun. 10(3):236-42. [Medline].

  25. Ward M, Sinn J. Steroid therapy for meconium aspiration syndrome in newborn infants. Cochrane Database Syst Rev. 2003. CD003485. [Medline].

  26. Sarkar S, Hussain N, Herson V. Fibrin glue for persistent pneumothorax in neonates. J Perinatol. 2003 Jan. 23(1):82-4. [Medline].

  27. [Guideline] 2005 American Heart Association (AHA) guidelines for cardiopulmonary resuscitation (CPR) and emergency cardiovascular care (ECC) of pediatric and neonatal patients: neonatal resuscitation guidelines. Pediatrics. 2006 May. 117(5):e1029-38. [Medline].

  28. Cialone PR, Sherer DM, Ryan RM, et al. Amnioinfusion during labor complicated by particulate meconium-stained amniotic fluid decreases neonatal morbidity. Am J Obstet Gynecol. 1994 Mar. 170(3):842-9. [Medline].

  29. Dargaville PA, Copnell B. The epidemiology of meconium aspiration syndrome: incidence, risk factors, therapies, and outcome. Pediatrics. 2006 May. 117(5):1712-21. [Medline].

  30. Dargaville PA, South M, McDougall PN. Surfactant and surfactant inhibitors in meconium aspiration syndrome. J Pediatr. 2001 Jan. 138(1):113-5. [Medline].

  31. Glantz JC, Woods JR. Significance of amniotic fluid meconium. Maternal-Fetal Medicine. 1999. 393-403.

  32. Kattwinkel J, Niermeyer S, Denson SE. Textbook of Neonatal Resuscitation. 2000.

  33. Kinsella JP. Meconium aspiration syndrome: is surfactant lavage the answer?. Am J Respir Crit Care Med. 2003 Aug 15. 168(4):413-4. [Medline].

  34. Korones SB, Bada-Ellzey HS. Meconium aspiration. Neonatal Decision Making. 1993. 128-9.

  35. Kugelman A, Gangitano E, Taschuk R, et al. Extracorporeal membrane oxygenation in infants with meconium aspiration syndrome: a decade of experience with venovenous ECMO. J Pediatr Surg. 2005 Jul. 40(7):1082-9. [Medline].

  36. Lo KW, Rogers M. A controlled trial of amnioinfusion: the prevention of meconium aspiration in labour. Aust N Z J Obstet Gynaecol. 1993 Feb. 33(1):51-4. [Medline].

  37. Ranzini AC, Chan L. Meconium and fetal-neonatal compromise. In: Intensive Care of the Fetus and Neonate. 1996: 297-303.

  38. Roberton NRC. Aspiration syndromes. Neonatal Respiratory Disorders. 1996. 313-33.

  39. Soll RF, Dargaville P. Surfactant for meconium aspiration syndrome in full term infants. Cochrane Database Syst Rev. 2000. [Medline].

  40. Usta IM, Mercer BM, Aswad NK, Sibai BM. The impact of a policy of amnioinfusion for meconium-stained amniotic fluid. Obstet Gynecol. 1995 Feb. 85(2):237-41. [Medline].

  41. Whitsett JA, Pryhuber GS, Rice WR, Warner BB, Wert SE. Acute respiratory disorders. Neonatology: Pathophysiology and Management of the Newborn. 1999. 494-508.

  42. Wiswell TE, Gannon CM, Jacob J, et al. Delivery room management of the apparently vigorous meconium-stained neonate: results of the multicenter, international collaborative trial. Pediatrics. 2000 Jan. 105(1 Pt 1):1-7. [Medline]. [Full Text].

  43. Yeh TF. Core Concepts: Meconium Aspiration Syndrome. NeoReviews. 2010. 11:e503-511.

  44. Young TE, Mangum OB. Neofax: A Manual of Drugs Used in Neonatal Care. 1998.

Air trapping and hyperexpansion from airway obstruction.
Acute atelectasis.
Pneumomediastinum from gas trapping and air leak.
Left pneumothorax with depressed diaphragm and minimal mediastinal shift because of noncompliant lungs.
Diffuse chemical pneumonitis from constituents of meconium.
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.